Related Experiment Video
Updated: Jan 23, 2026

Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
Revisiting the role of autophagy in melanoma
Shun Li1, Ying Song1, Christine Quach1
1Department of Molecular Microbiology and Immunology, University of Southern California , Los Angeles , CA , USA.
Abstract:
Although alterations of the macroautophagy/autophagy-lysosome pathway have been observed in cancer for many years, the mechanisms underlying these changes and the importance of autophagic and lysosomal reprogramming by cancer have yet to be well identified. Our recent study demonstrates that oncogenic BRAF signaling promotes melanoma growth and resistance to BRAF-targeted therapy through phosphorylation and functional inactivation of TFEB (transcription factor EB) and consequent suppression of the autophagy-lysosome gene network. This is by no means the first time that this pathway has been directly linked to oncogenic BRAF-driven melanoma. The key observations revealed in this study also leads to a complex but growing convergence of our understanding of the biology of the autophagy-lysosome pathway and the mechanisms underlying cancer prevention and treatment.
Insights
Oncogenic BRAF signaling drives melanoma growth and therapy resistance by inactivating TFEB, a key regulator of the autophagy-lysosome pathway. This study reveals crucial mechanisms in cancer reprogramming.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Alterations in the autophagy-lysosome pathway are common in cancer, but the underlying mechanisms and functional significance remain unclear.
- Autophagic and lysosomal reprogramming plays a role in cancer progression and treatment resistance.
- The specific role of oncogenic BRAF signaling in regulating this pathway in melanoma is an area of active investigation.
Purpose of the Study:
- To elucidate the mechanisms by which oncogenic BRAF signaling influences the autophagy-lysosome pathway in melanoma.
- To investigate the role of TFEB (transcription factor EB) in mediating BRAF-driven melanoma growth and therapy resistance.
- To understand how BRAF-induced suppression of the autophagy-lysosome gene network contributes to cancer progression.
Main Methods:
- Investigated the phosphorylation and functional inactivation of TFEB by oncogenic BRAF signaling.
- Analyzed the impact of BRAF signaling on the autophagy-lysosome gene network.
- Utilized models of BRAF-driven melanoma to assess tumor growth and response to BRAF-targeted therapy.
Main Results:
- Demonstrated that oncogenic BRAF signaling phosphorylates and inactivates TFEB.
- Showed that TFEB inactivation leads to the suppression of the autophagy-lysosome gene network.
- Confirmed that this suppression promotes melanoma growth and resistance to BRAF-targeted therapy.
Conclusions:
- Oncogenic BRAF signaling is a key driver of melanoma progression and therapy resistance through TFEB inactivation and autophagy-lysosome pathway suppression.
- Understanding these mechanisms offers new insights into cancer prevention and treatment strategies.
- This study highlights the critical role of the autophagy-lysosome pathway in BRAF-driven melanoma biology.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Role of Culture
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Role of Amygdala in Memory
One of the...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

